European Commission calls for reversal of Illumina's $7bn Grail merger

The commission on Monday sent a "statement of objections" outlining the process Illumina must follow in divesting Grail, its blood-testing...

Rewind Therapeutics extends Series A financing

The company, founded by CD3 (Leuven, Belgium) and Axxam S.p.A. (Milan), did not want to reveal the exact amount added to the €15.2m in its 2018...

Ultra-processed foods increase risk for cancer

According to a long-term data from the UK biobank, high consumption of ultra-processed foods are linked to bad health outcomes such as diabetes,-...

BioNTech and Ryvu Therapeutics enter into global collaboration

BioNTech SE and Ryvu Therapeutics S.A. announced that the companies have entered into a multi-target research collaboration targeting immune...

Healthcare investments in Catalonia at record high

According to the 2021 BioRegion of Catalonia Report, the medical technology sector attracted most of the money, fueled by two large operations....

Collaboration to develop mRNA vaccine against betacoronaviruses

Ethris GmbH a German company specialising in the development of mRNA vaccines, announced their collaboration with DIOSynVax Ltd., an English biotech...

New partnerships push InDevR for Series B financing

Investments into InDevR, Inc. came from New York-based Adjuvant Capital ($4m) and French bioMèrieux SA ($5m), which will enable the commercial...